Biogen Inc (NASDAQ:BIIB)

266.02
Delayed Data
As of Apr 19
 -2.01 / -0.75%
Today’s Change
244.28
Today|||52-Week Range
370.57
-16.50%
Year-to-Date

Today’s Trading

Previous close268.03
Today’s open267.69
Day’s range264.82 - 271.05
Volume910,917
Average volume (3 months)1,556,674
Market cap$60.5B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-29.56%
Earnings growth (this year)+13.87%
Earnings growth (next 5 years)+5.57%
Revenue growth (last year)+7.81%
P/E ratio22.3
Price/Sales6.17
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-4.16-1.66%
GILDGilead Sciences-1.24-1.64%
----
----
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateApril 24, 2018
EPS forecast (this quarter)$5.92
Annual revenue (last year)$11.0B
Annual profit (last year)$2.5B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts